Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) …

Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price TargetAlnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis - MarketBeatAlnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History


Install CouponFollow Chrome Extension   CouponFollow Extension

$294.50
OFF

Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price Target

1 week from now

5 days ago  · Consensus Price Target. According to the 24 analysts' twelve-month price targets for Alnylam Pharmaceuticals, the average price target is $294.50. The highest price target for …

marketbeat.com

$307.00
OFF

Alnylam Pharmaceuticals (NASDAQ:ALNY) Receives “Buy” Rating …

1 week from now

Nov 4, 2024  · Bank of America lifted their price objective on shares of Alnylam Pharmaceuticals from $307.00 to $314.00 and gave the company a “buy” rating in a research note on Monday, …

etfdailynews.com

$322.83
OFF

Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst ... - Nasdaq

1 week from now

4 days ago  · 0. In the assessment of 12-month price targets, analysts unveil insights for Alnylam Pharmaceuticals, presenting an average target of $322.83, a high estimate of $400.00, and a …

nasdaq.com

$0.87
OFF

Alnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis

1 week from now

4 days ago  · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) posted its earnings results on Thursday, October, 31st. The biopharmaceutical company reported ($0.87) earnings per share …

marketbeat.com

67%
OFF

ALNY Stock Price | Alnylam Pharmaceuticals Inc. Stock Quote (U.S ...

1 week from now

6 days ago  · 1.67%. $2.72B. ALNY | Complete Alnylam Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

marketwatch.com

86%
OFF

Alnylam Pharmaceuticals, Inc. (ALNY) Company Profile & Overview …

1 week from now

May 28, 2004  · NASDAQ: ALNY · Real-Time Price · USD. Watchlist Compare. 279.82 +2.39 (0.86%) At close: Nov 11, 2024, 4:00 PM. 278.88-0.94 (-0.34%) After-hours: Nov 11, 2024, …

stockanalysis.com

$198.00
OFF

Alnylam Pharmaceuticals (NASDAQ:ALNY) Cut To ... - ETF Daily News

1 week from now

2 days ago  · The Goldman Sachs Group raised Alnylam Pharmaceuticals from a “neutral” rating to a “buy” rating and lifted their price target for the company from $198.00 to $370.00 in a …

etfdailynews.com

$234.88
OFF

Alnylam Pharmaceuticals Enters Oversold Territory (ALNY)

1 week from now

1 day ago  · In trading on Friday, shares of Alnylam Pharmaceuticals Inc (Symbol: ALNY) entered into oversold territory, hitting an RSI reading of 28.5, after changing hands as low as $234.88 …

nasdaq.com

4%
OFF

Los Angeles Capital Management LLC Buys 135,829 Shares Of …

1 week from now

6 days ago  · Los Angeles Capital Management LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 11,433.4% during the 3rd quarter, …

marketbeat.com

299%
OFF

Stock Indexes Slightly Higher As They Consolidate Below Record …

1 week from now

4 days ago  · European government bond yields today are moving higher. The 10-year German bund yield rebounded from a 1-1/2 week low of 2.299% and is up +1.5 bp to 2.342%.

nasdaq.com

FAQs about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) … Coupon?

What is the target price for Alnylam Pharmaceuticals (ALNY)?

The average 1-year target price for Alnylam Pharmaceuticals' shares, based on 21 equities research analysts, is $234.76. Their price targets range from $143.00 to $395.00, suggesting a possible upside of 43.2% from the current price. ...

Is Alnylam Pharmaceuticals a buy?

The Goldman Sachs Group upgraded Alnylam Pharmaceuticals from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $198.00 to $370.00 in a report on Friday, August 16th. ...

Why did Alnylam Pharmaceuticals (ALNY) open more than 30% on Monday?

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) opened more than 30% up on Monday after reporting promising results from a late-stage trial of its heart drug. Shares of the biopharmaceutical company are n... ...

Who founded Alnylam Pharmaceuticals Inc?

The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA. ALNY | Complete Alnylam Pharmaceuticals Inc. stock news by MarketWatch. ...

Is Alnylam Pharmaceuticals a RNAi company?

CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter endi... ...

When is Alnylam Pharmaceuticals' next earnings announcement?

Alnylam Pharmaceuticals' next earnings announcement is scheduled for Thursday, November 2nd 2023. The company will be holding an earnings conference call on this day at 8:30 AM Eastern. For more information, view our ALNY earnings forecast. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension